NUTRIBAND INC. Gain (Loss) on Extinguishment of Debt
NUTRIBAND INC. (NTRB) reported Gain (Loss) on Extinguishment of Debt of -$368.04 thousand for the 12-month period ending 2025-01-31, per its 10-K filed 2026-04-29.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2026-04-29
- NUTRIBAND INC. gain (loss) on extinguishment of debt for the quarter ending 2025-01-31 was $0.00.
- NUTRIBAND INC. gain (loss) on extinguishment of debt for the quarter ending 2024-10-31 was $0.00.
- NUTRIBAND INC. gain (loss) on extinguishment of debt for the quarter ending 2024-07-31 was -$368.04K.
- NUTRIBAND INC. gain (loss) on extinguishment of debt for the quarter ending 2022-01-31 was $9.81K.
- NUTRIBAND INC. gain (loss) on extinguishment of debt for fiscal 2025 was -$368.04K.
- NUTRIBAND INC. gain (loss) on extinguishment of debt for fiscal 2024 was -$554.42K.
- NUTRIBAND INC. gain (loss) on extinguishment of debt for fiscal 2022 was $53.03K.
- NUTRIBAND INC. gain (loss) on extinguishment of debt for fiscal 2021 was -$12.50K.
| Period end | Gain (Loss) on Extinguishment of Debt 1 month | Gain (Loss) on Extinguishment of Debt 3 month | Gain (Loss) on Extinguishment of Debt 6 month | Gain (Loss) on Extinguishment of Debt 9 month | Gain (Loss) on Extinguishment of Debt 12 month |
|---|---|---|---|---|---|
| 2025-01-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-29 | $0.00 derived: sum of 2 quarters · filed 2026-04-29 | -$368.04K derived: sum of 3 quarters · filed 2026-04-29 | -$368.04K 10-K · filed 2026-04-29 | |
| 2024-10-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-12-11 | -$368.04K derived: sum of 2 quarters · filed 2025-12-11 | -$368.04K 10-Q · filed 2025-12-11 | ||
| 2024-07-31 | -$368.04K 10-Q · filed 2025-09-09 | -$368.04K 10-Q · filed 2025-09-09 | |||
| 2024-01-31 | -$554.42K 10-K · filed 2025-04-28 | ||||
| 2022-01-31 | $9.81K derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-26 | $9.81K derived: sum of 2 quarters · filed 2023-04-26 | $13.15K derived: sum of 3 quarters · filed 2023-04-26 | $53.03K 10-K · filed 2023-04-26 | |
| 2021-10-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-12-02 | $3.34K derived: sum of 2 quarters · filed 2022-12-02 | $43.21K 10-Q · filed 2022-12-02 | $43.21K derived: sum of 4 quarters · filed 2022-12-02 | |
| 2021-07-31 | $3.34K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-09-08 | $43.21K 10-Q · filed 2022-09-08 | $43.21K derived: sum of 3 quarters · filed 2022-09-08 | $43.21K derived: sum of 4 quarters · filed 2022-09-08 | |
| 2021-04-30 | $39.88K 10-Q · filed 2021-06-14 | $39.88K derived: sum of 2 quarters · filed 2021-06-14 | $39.88K derived: sum of 3 quarters · filed 2021-06-14 | $39.88K derived: sum of 4 quarters · filed 2021-06-14 | |
| 2021-01-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-04-02 | $0.00 derived: sum of 2 quarters · filed 2021-04-02 | $0.00 derived: sum of 3 quarters · filed 2021-04-02 | -$12.50K 10-K · filed 2021-04-02 | |
| 2020-10-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-12-15 | $0.00 derived: sum of 2 quarters · filed 2020-12-15 | -$12.50K 10-Q · filed 2020-12-15 | ||
| 2020-07-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-09-11 | -$12.50K 10-Q · filed 2020-09-11 | |||
| 2020-04-30 | -$12.50K 10-Q · filed 2021-06-14 | ||||
| 2020-03-27 | $12.50K 10-Q · filed 2020-09-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |
| Envoy Medical, Inc. (COCH) | United States | $0.056B | |
| ALPHA PRO TECH LTD (APT) | $0.052B | 13.63 | |
| MILESTONE SCIENTIFIC INC. (MLSS) | United States | $0.036B | -6.85 |
| Lifeward Ltd. (LFWD) | $0.021B | ||
| ENvue Medical, Inc. (FEED) | United States | $0.011B |